Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

AIMS: Non-vitamin K oral anticoagulants are safe and effective for stroke prevention in patients with atrial fibrillation (AF). Data on the safety and efficacy of edoxaban in routine care are limited in Europe. We report 1-year outcomes in patients with AF treated with edoxaban in routine care. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: de Groot, Joris R, Weiss, Thomas W, Kelly, Peter, Monteiro, Pedro, Deharo, Jean Claude, de Asmundis, Carlo, López-de-Sá, Esteban, Waltenberger, Johannes, Steffel, Jan, Levy, Pierre, Bakhai, Ameet, Zierhut, Wolfgang, Laeis, Petra, Manu, Marius Constantin, Reimitz, Paul-Egbert, De Caterina, Raffaele, Kirchhof, Paulus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117428/
https://www.ncbi.nlm.nih.gov/pubmed/32790837
http://dx.doi.org/10.1093/ehjcvp/pvaa079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117428/
https://www.ncbi.nlm.nih.gov/pubmed/32790837
http://dx.doi.org/10.1093/ehjcvp/pvaa079

Ejemplares similares